Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

Name: Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
Published: 2006
License: Public Domain

The University of New South Wales · 2006

ClinicalTrials.gov · Datasets · License: Public Domain · 2006

Open Source ↗

leukemia

leukemia, myelodysplastic syndromes, untreated adult acute myeloid leukemia, de novo myelodysplastic syndromes, secondary acute myeloid leukemia, secondary myelodysplastic syndromes, previously treated myelodysplastic syndromes, refractory anemia with excess blasts, adult acute basophilic leukemia, adult acute eosinophilic leukemia, adult acute megakaryoblastic leukemia (m7), adult acute minimally differentiated myeloid leukemia (m0)

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 906759
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.